American Healthcare REIT, Inc. (AHR) Company Overview

US | Real Estate | REIT - Healthcare Facilities | NYSE

What does American Healthcare REIT do?

American Healthcare REIT, Inc. is a New York Stock Exchange-listed real estate investment trust focused on healthcare properties where the real estate and the delivery of care are closely connected. Its portfolio spans senior housing, integrated senior health campuses, skilled nursing, outpatient medical buildings and a smaller group of triple-net leased facilities. The company’s investor-relations overview describes a clinically oriented portfolio across the United States, the United Kingdom and the Isle of Man.

343
Buildings and integrated senior health campuses owned or operated at March 31, 2026
22.7M
Square feet of gross leasable area at March 31, 2026
$5.61B
Aggregate contract purchase price of the property portfolio at March 31, 2026
$5.60B
Total assets reported at March 31, 2026

Which operating platforms define the portfolio?

AHR reports four segments. Integrated Senior Health Campuses, or ISHC, combine independent living, assisted living, memory care and skilled nursing. Senior Housing Operating Properties, or SHOP, are run through regional managers. Outpatient Medical, or OM, consists mainly of medical offices, while triple-net leases shift most property costs to tenants.

Integrated Senior Health Campuses
58.3%
Share of annualized base rent or NOI at March 31, 2026; operated through the Trilogy platform.
Senior Housing Operating Properties
19.2%
Share of annualized base rent or NOI at March 31, 2026; direct exposure to occupancy and resident rates.
Outpatient Medical
16.5%
Share of annualized base rent or NOI at March 31, 2026; a steadier lease-oriented business.
Triple-Net Leased
6.0%
Share of annualized base rent or NOI at March 31, 2026; tenants generally bear property-level costs.
NYSE: AHR Healthcare REIT Senior housing Skilled nursing Outpatient medical RIDEA exposure

This mix makes AHR more operationally sensitive than a rent-only REIT. Occupancy and resident-rate gains can lift revenue, but labor and other property costs also move with the business. The quarterly Form 10-Q for March 31, 2026 should therefore be read as both a real-estate and operating-company report.

How does American Healthcare REIT make money?

AHR uses two economic models. Under RIDEA, taxable REIT subsidiaries lease ISHC and SHOP properties and engage third-party managers, while AHR retains exposure to resident fees and operating costs. In the landlord model, OM tenants pay rent and triple-net tenants generally cover taxes, insurance and maintenance.

01
Acquire or develop clinical real estate
Equity and debt fund senior housing, campuses and medical offices.
02
Choose operating structure
RIDEA retains operating upside; leases emphasize contractual rent.
03
Drive occupancy and rates
Demand, reimbursement, care mix and local execution shape revenue.
04
Convert revenue into NOI
Labor and property costs determine NOI conversion.
05
Fund distributions and reinvestment
NFFO, liquidity and sales fund dividends, growth and debt management.

Why does the operating model create both upside and volatility?

Operating exposure can outgrow fixed rent when occupancy and resident rates rise, but AHR also absorbs wage, insurance and other variable costs. In Q1 2026, resident fees and services were $609.8 million, about 93.7% of revenue, versus $41.0 million of real-estate revenue. Care operations now drive the earnings profile.

Segment Revenue mechanism Primary margin drivers Q1 2026 revenue
ISHC Resident fees, clinical services and skilled-nursing reimbursement Occupancy, resident rate, acuity mix, reimbursement and labor $502.7M
SHOP Private-pay senior housing resident fees Occupancy, rent growth, operator execution and staffing costs $107.0M
Outpatient Medical Contractual rent from medical-office tenants Leasing spreads, retention, occupancy and building expenses $30.8M
Triple-Net Leased Contractual rent with tenant-paid property costs Tenant credit, lease escalators and renewal economics $10.2M

Which segments drive AHR’s revenue and net operating income?

ISHC is the financial center of gravity. It generated $502.7 million of Q1 2026 segment revenue and $71.8 million of segment NOI, far more than any other segment. SHOP contributed $107.0 million of revenue and $25.8 million of NOI. OM and triple-net were smaller in revenue but carried higher property-level margins because they do not include the same resident-service cost base.

Segment revenue ranking
Quarter ended March 31, 2026
ISHC $502.7M
SHOP $107.0M
Outpatient Medical $30.8M
Triple-Net $10.2M
ISHC produced about 77% of consolidated revenue in Q1 2026, so campus occupancy, reimbursement and labor execution dominate the top-line story.

How different is the economic mix from the revenue mix?

Revenue overstates ISHC’s economic weight because resident-service expenses pass through the income statement. At March 31, 2026, annualized base rent or NOI was 58.3% ISHC, 19.2% SHOP, 16.5% OM and 6.0% triple-net. Leased assets therefore matter more than their revenue totals suggest.

Annualized base rent or NOI mix
Portfolio mix at March 31, 2026
ISHC — 58.3%
SHOP — 19.2%
Outpatient Medical — 16.5%
Triple-Net — 6.0%
Operating assets supplied 77.5% of the mix; leased assets supplied 22.5%.
Segment Q1 2026 revenue Q1 2026 NOI Implied property-level NOI margin Interpretation
ISHC $502.7M $71.8M 14.3% Largest profit pool, but labor-intensive and reimbursement-sensitive.
SHOP $107.0M $25.8M 24.1% High operating leverage when occupancy and resident rates rise.
Outpatient Medical $30.8M $18.7M 60.7% Lease revenue produces a higher margin but slower current growth.
Triple-Net $10.2M $9.2M 90.4% Minimal property expenses, offset by tenant-credit and concentration risk.

The strategic tension is clear: ISHC and SHOP offer stronger organic growth, while OM and triple-net provide steadier contractual economics. AHR’s valuation is increasingly tied to operating execution.

What does AHR’s latest quarter show?

Q1 2026 extended the operating momentum reported in 2025. AHR’s official Q1 2026 earnings release, total revenue rose 20.4% year over year to $650.8 million. Net income attributable to controlling interest was $23.7 million, or $0.13 per diluted share, while normalized funds from operations reached $94.8 million, or $0.50 per share.

$650.8M
Total revenue, Q1 2026; up 20.4% year over year
$125.5M
Total segment NOI, Q1 2026; up 32.8% year over year
$0.50
Normalized FFO per share, Q1 2026; more than 30% year-over-year growth
12.1%
Total portfolio same-store NOI growth, Q1 2026

Where did the growth come from?

The operating portfolio led growth: SHOP same-store NOI rose 19.7%, ISHC 14.5%, triple-net 4.6% and OM 1.6%. Acquisitions completed in 2025 and early 2026 also expanded the asset base, helping NOI rise faster than revenue.

Metric Q1 2026 Q1 2025 What changed
Total revenue $650.8M $540.6M 20.4% growth from acquisitions and operating improvement.
Total segment NOI $125.5M $94.5M 32.8% growth, showing positive operating leverage.
Net income attributable to controlling interest $23.7M $(6.8)M Improved from a loss as NOI rose and impairment charges fell.
Normalized FFO attributable $94.8M $59.7M Adjusts major non-cash real-estate items.
Operating cash flow $81.1M $60.6M 33.7% growth, supporting distributions and reinvestment.

What do cash flow and guidance say?

Q1 operating cash flow was $81.1 million, while development and capital expenditures were $38.3 million and acquisitions were $165.9 million. Equity and liquidity therefore match-funded growth. Management raised FY2026 guidance to $2.03–$2.09 of normalized FFO per share and 9%–12% same-store NOI growth.

Full-year baseline
$2.26B
FY2025 revenue, versus $2.07B in FY2024. FY2025 normalized FFO was $1.72 per share.
Current outlook
$2.03–$2.09
Normalized FFO per-share guidance for FY2026 after the Q1 2026 increase.

The full-year 2025 results provide the annual baseline: $69.8 million of net income attributable to controlling interest, $0.42 of diluted EPS, 14.2% total same-store NOI growth and more than $950 million of investments completed during the year.

What turning points created today’s American Healthcare REIT?

AHR emerged through consolidation, internalization and a shift from a non-traded vehicle to a listed growth platform. Each turning point changed control, capital access or operating exposure.

  1. 2015–2016
    The predecessor REITs assembled the healthcare assets later combined into AHR.
  2. October 2021
    The predecessor REITs merged and acquired American Healthcare Investors, creating a self-managed company with more than 100 employees and targeted annual savings of about $21 million.
  3. February 2024
    AHR listed on the NYSE and raised about $772.8 million, using roughly $721.5 million to repay debt carrying a weighted-average rate near 7.5%.
  4. September 2024
    AHR bought the remaining 24% of Trilogy REIT Holdings for $258 million, gaining full economics in its main operating platform.
  5. Full year 2025
    AHR completed more than $950 million of investments, including about $370 million in ISHC and $590 million in SHOP.
  6. First quarter 2026
    AHR acquired $162.8 million of SHOP assets, reported a pipeline above $650 million and raised guidance.

Why did the 2021 internalization matter?

The 2021 merger announcement shows that AHR was designed as a self-managed platform rather than an externally advised vehicle. Internalization put investment, asset management and financing inside one organization and removed the external advisory structure.

Why is full ownership of Trilogy strategically important?

Trilogy operates ISHC, AHR’s largest earnings engine. The 2024 acquisition of the remaining Trilogy interest eliminated minority leakage and gave AHR full participation in campus growth, while increasing concentration in one operator.

Why are senior housing and integrated care campuses AHR’s strategic engine?

The operating portfolio serves a local, service-intensive need that is difficult to digitize. Licensed facilities, trained staff and referral relationships create barriers. Integrated campuses can retain residents as needs progress from independent living to assisted living, memory care or skilled nursing.

91.2%
ISHC same-store occupancy
Q1 2026 total same-store occupancy, up 220 basis points from 89.0% in Q1 2025. The green arc represents occupied capacity.

Which operating KPIs show the campus model working?

AHR’s Q1 2026 supplemental report shows 149 ISHC campuses with 15,222 beds and units. Total portfolio occupancy was 89.9%. The same-store subset included 115 campuses and 11,710 beds and units; occupancy reached 91.2%, while same-store revenue rose 6.9% and same-store NOI rose 14.5%.

ISHC cash NOI trend
Five quarters ended March 31, 2026
$60.2M Q1 2025
$68.0M Q2 2025
$69.2M Q3 2025
$70.8M Q4 2025
$78.5M Q1 2026
ISHC cash NOI increased across the five-quarter series, with the largest step-up in Q1 2026.
20.1% ISHC same-store cash NOI margin in Q1 2026, up 134 basis points year over year as revenue growth outpaced operating-expense growth.

Filling existing capacity creates operating leverage because many campus costs are already in place. The effect reverses when occupancy weakens or wages outpace resident revenue, so occupancy and cash NOI margin must be read together.

What gives AHR a competitive advantage, and who are its main peers?

AHR’s advantage combines scale, clinical operating knowledge, public-equity access, regional operator relationships and an integrated-campus platform. It can buy assets that are too operationally complex for passive landlords and improve them through specialized managers.

AHR’s moat is strongest where real-estate ownership, local care delivery and operating data reinforce one another; it is weakest where assets behave like commoditized leased buildings.

Which resources are difficult for a new entrant to reproduce?

Integrated campus platform Strong
Q1 2026 scale creates operating knowledge and referral continuity.
Capital access Strong
Public-market access and $1.31B of Q1 2026 liquidity support acquisitions.
Contractual protection Moderate
OM and triple-net provide leases, but most economic exposure now comes from operating segments.
Geographic diversification Limited
Indiana represented 35.6% and Ohio 13.7% of annualized base rent or NOI at March 31, 2026.

How does AHR compare with public healthcare REIT peers?

AHR’s 2026 proxy peer group includes CareTrust, Healthpeak, Healthcare Realty, LTC, National Health Investors, Omega, Sabra and Sila. They frame competition for healthcare assets and investor capital.

Competitive dimension AHR position Peer pressure Strategic implication
Operating senior housing exposure High through ISHC and SHOP Peers compete for communities, operators and development opportunities. AHR can capture operating upside but must prove repeatable execution.
Skilled nursing and integrated care Distinctive Trilogy campus concentration Omega, CareTrust, Sabra and NHI compete for skilled-nursing capital deployment. Clinical complexity can be a barrier, but reimbursement and labor risks are higher.
Medical-office exposure Meaningful but not the primary growth engine Healthpeak and Healthcare Realty have larger medical-office platforms. OM adds stability, although Q1 2026 same-store NOI growth was only 1.6%.
Cost of capital Improved after listing and deleveraging Larger, seasoned REITs may access capital at lower spreads. Acquisition value depends on maintaining an attractive spread over funding costs.

The advantage is conditional: operator quality, disciplined funding and acquisition returns must appear in occupancy, same-store NOI and per-share NFFO growth.

How financially strong is American Healthcare REIT?

AHR entered 2026 with a stronger capital structure. At March 31, total debt was about $1.53 billion, liquidity was $1.31 billion and net debt to annualized adjusted EBITDA was 3.0x, down from 3.4x at year-end 2025. Cash was $119.4 million and total equity was $3.52 billion.

Liquidity and leverage
3.0x
Net debt to annualized adjusted EBITDA at March 31, 2026, with $1.31B of total liquidity.
Debt pricing
4.14%
Overall effective debt rate including interest-rate swaps at March 31, 2026.

How exposed is AHR to interest rates?

AHR had 85 fixed-rate mortgage loans with $980.0 million of principal at a 3.73% weighted-average effective rate. Credit-facility and term-loan principal was $550.0 million at 4.98%. All variable balances were swapped at quarter-end, limiting near-term rate sensitivity, although maturity refinancing risk remains.

Financial item Official period Amount or ratio Research interpretation
Cash and cash equivalents March 31, 2026 $119.4M Immediate liquidity; the revolver and equity program fund larger deals.
Mortgage debt March 31, 2026 $962.4M net Mostly fixed-rate property debt.
Credit facility and term loan March 31, 2026 $549.8M net Flexible funding with swapped variable exposure.
Operating cash flow Q1 2026 $81.1M Covered Q1 cash distributions before growth investment.
Development and capital expenditures Q1 2026 $38.3M Supports future NOI but reduces current cash residual.
Development and expansion pipeline March 31, 2026 $173.9M expected cost Only $52.4M was funded, leaving future capital needs.

How does AHR allocate capital?

AHR match-funds growth with equity, asset sales and moderate leverage. In Q1 2026 it entered forward sales for about 7.0 million shares and $357.4 million of gross proceeds, then settled about 4.0 million shares for $191.2 million. Unsettled forwards represented $527.4 million of potential gross proceeds at May 7.

50% The Q1 2026 distribution of $0.25 per share equaled half of Q1 normalized FFO of $0.50 per share, leaving room for reinvestment before other cash needs.

AHR’s June 2026 distribution filing maintained the quarterly dividend at $0.25 per share, or $1.00 annually. The valuation question is whether acquisition returns and same-store growth exceed funding costs and dilution.

Who owns AHR stock, and how is the company governed?

AHR uses one share, one vote rather than a founder-controlled dual-class structure. The 2026 proxy statement reports 191,870,178 common shares outstanding on the April 1, 2026 record date, with each share entitled to one vote.

Holder or governance group Economic stake or shares Source period Why it matters
BlackRock, Inc. 24,609,199 shares; 12.8% Proxy ownership table, 2026 A large passive holder can influence elections without controlling strategy.
Directors and executive officers as a group 1,439,439 common shares plus 1,268,643 shared OP units; under 1% of common stock Proxy ownership table, 2026 Insiders have exposure, but voting control remains dispersed.
Board of directors 9 directors; 7 independent 2026 annual meeting materials Independent oversight matters for acquisitions, leverage and succession.
Board committees Audit, compensation, and nominating and corporate governance committees 2026 proxy All three standing committees are fully independent.

What does dispersed ownership mean for strategy?

With no insider voting control, management must retain broad institutional support. That increases scrutiny of per-share NFFO growth, leverage and whether equity issuance is accretive.

How should researchers interpret current leadership?

Danny Prosky began medical leave in February 2026 and remained a director. Chairman Jeff Hanson became interim CEO and president. AHR intends to separate the chairman and CEO roles when Prosky returns, making independent-board succession oversight important.

What opportunities and risks could change AHR’s outlook?

AHR can grow through further occupancy gains, resident-rate increases, development and acquisitions. The Q1 2026 investment pipeline exceeded $650 million; the company acquired $162.8 million of SHOP assets in the quarter and $86.4 million after quarter-end.

Growth case
9%–12%
FY2026 total portfolio same-store NOI growth guidance after Q1 2026.
Execution constraint
$650M+
Investment pipeline at Q1 2026; opportunities are not earnings until transactions close and assets perform.

Which growth drivers are most credible?

Organic same-store growth is the highest-quality driver because it uses existing assets without immediate dilution. Development adds units in proven markets, while acquisitions expand the platform if pricing is disciplined. AHR’s 2025 acquisition activity announcement shows deployment capacity, but value depends on integration and per-share returns.

What risks appear most material in the filings?

Risk Company-specific exposure Financial line to monitor Early warning signal
Labor and operating-cost inflation ISHC and SHOP absorb staffing costs. Property operating expense and cash NOI margin Revenue growth no longer exceeds expense growth.
Occupancy reversal Operating leverage depends on occupied capacity. Same-store occupancy and same-store NOI Sequential occupancy declines or weaker move-in activity.
Reimbursement and regulation Skilled-nursing revenue depends on public payers and licensing compliance. ISHC resident fees, bad debt and compliance costs Rate pressure, audit findings or delayed reimbursements.
Geographic concentration Indiana was 35.6% and Ohio 13.7% of annualized base rent or NOI at March 31, 2026. Regional occupancy, labor and state reimbursement Policy or labor deterioration in core markets.
Acquisition and development execution AHR is acquiring, renovating and expanding assets. Capex, development cost, NOI ramp and impairment Cost overruns, delays or weak returns.
Equity dilution and cost of capital Growth uses forward equity sales. NFFO per share, share count and acquisition yield Asset growth without per-share growth.

The 2025 Form 10-K also emphasizes operator performance, cybersecurity, insurance, REIT tax qualification and acquisition execution. These risks can compound when operating cash flow weakens as capital needs rise.

What is the key takeaway for American Healthcare REIT?

AHR is evolving from a diversified property owner into an operating senior-housing and integrated-care platform. That raises growth potential but increases exposure to occupancy, labor, reimbursement and operator execution. The key question is whether NOI and acquisition returns compound faster than funding costs and share issuance.

Which metrics matter most in a valuation model?

A REIT valuation should start with normalized FFO or distributable cash, then separately model segment NOI, corporate costs, cash interest, recurring capex, development and incremental shares. Terminal assumptions should use normalized occupancy and margins rather than extrapolate recovery indefinitely.

ISHC same-store occupancy
Q1 2026 was 91.2%. Watch whether gains continue without sacrificing pricing or care quality.
SHOP same-store NOI growth
Q1 2026 was 19.7%. A deceleration would test the operating-growth thesis.
ISHC cash NOI margin
Q1 2026 same-store margin was 20.1%. Labor productivity determines whether occupancy converts to cash profit.
Normalized FFO per share
FY2026 guidance is $2.03–$2.09. Per-share growth must keep pace with equity issuance.
Net debt to adjusted EBITDA
The ratio was 3.0x at March 31, 2026. Staying moderate preserves acquisition flexibility.
Acquisition spread
Compare stabilized asset yields with the blended cost of debt and equity, not with purchase volume alone.
Development funding
Only $52.4M of a $173.9M expected pipeline cost was funded at March 31, 2026.
Regional concentration
Indiana and Ohio together represented 49.3% of annualized base rent or NOI at March 31, 2026.
Final synthesis
AHR is supported by improving occupancy, double-digit operating-portfolio NOI growth, full Trilogy ownership and low leverage. The same operating exposure also transmits labor, reimbursement, regional and execution risk into earnings. It is best viewed as a hybrid real-estate owner and operating platform, judged on durable per-share cash-flow growth rather than acquisition volume.

DCF model

    5-Year Financial Model

    40+ Charts & Metrics

    DCF & Multiple Valuation

    Free Email Support



Disclaimer

All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.

We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.

All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

(AHR) American Healthcare REIT, Inc. Bundle

Get Full Bundle:
$17 $9
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5
$9 $5